1-[7-(1-Methyl-1H-pyrazol-4-yl)-1,5-naphthyridin-2-yl]-3-(2-phenylethyl)urea

ID: ALA3318030

PubChem CID: 53239587

Max Phase: Preclinical

Molecular Formula: C21H20N6O

Molecular Weight: 372.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2cnc3ccc(NC(=O)NCCc4ccccc4)nc3c2)cn1

Standard InChI:  InChI=1S/C21H20N6O/c1-27-14-17(13-24-27)16-11-19-18(23-12-16)7-8-20(25-19)26-21(28)22-10-9-15-5-3-2-4-6-15/h2-8,11-14H,9-10H2,1H3,(H2,22,25,26,28)

Standard InChI Key:  AEBGAQZHEWUQER-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    8.5669   -4.3336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8578   -3.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6860   -3.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2719   -3.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1041   -3.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5182   -3.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3950   -4.3336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1041   -3.1078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9810   -4.3336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.5182   -3.1078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8132   -2.6992    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6860   -3.1078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8132   -4.3336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2719   -3.1078    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3950   -2.6992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2273   -4.3336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3134   -5.1466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1141   -5.3161    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5227   -4.6069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9745   -3.9993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4471   -6.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1505   -4.3342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1548   -5.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4535   -5.5494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4574   -6.3597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1626   -6.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8651   -6.3487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8577   -5.5397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6 16  1  0
  3 12  1  0
  7  5  1  0
 12 15  2  0
  4 14  2  0
 15  8  1  0
 10  6  2  0
 11 10  1  0
  7  3  2  0
 13  5  2  0
  8 11  2  0
  9  3  1  0
  4  9  1  0
  1  4  1  0
  1  2  1  0
  6 13  1  0
  8  5  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 18 21  1  0
  2 22  1  0
 23 22  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END

Associated Targets(Human)

HIPK1 Tchem Homeodomain-interacting protein kinase 1 (1559 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YES1 Tclin Tyrosine-protein kinase YES (2781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.43Molecular Weight (Monoisotopic): 372.1699AlogP: 3.39#Rotatable Bonds: 5
Polar Surface Area: 84.73Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.78CX Basic pKa: 2.57CX LogP: 3.11CX LogD: 3.11
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.56Np Likeness Score: -2.00

References

1. Defaux J, Antoine M, Logé C, Le Borgne M, Schuster T, Seipelt I, Aicher B, Teifel M, Günther E, Gerlach M, Marchand P..  (2014)  Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.,  24  (16): [PMID:25022204] [10.1016/j.bmcl.2014.06.078]

Source